BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
Carbohydrate antigen 125 (CA 125) is highly glycosylated mucin found on the surface of ovarian cancer cells, encoded by the MUC16 gene, and was first identified as an ovarian cancer antigen in 1981. The antigen is rarely present in normal serum or in adult or fetal ovaries. As a tumor marker, CA 125 can be used in the diagnosis and treatment of ovarian cancer.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.